DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Focus forming assay are 23




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_5245Cytarabine
NA
Leukemia
Variola virus
Harvey
NA
Focus forming assay
Decrease (82.3 %)
Approved
198636
DrugRepV_5246Cytarabine
NA
Leukemia
Variola virus
Harvey
NA
Focus forming assay
Decrease (30.2 %)
Approved
198636
DrugRepV_52476-Azauridine
NA
Cancer
Variola virus
Harvey
NA
Focus forming assay
Decrease (1.2 %)
NA
198636
DrugRepV_5248Cytarabine
NA
Leukemia
Variola virus
Yamamoto P
NA
Focus forming assay
Decrease (66.1 %)
Approved
198636
DrugRepV_52496-Azauridine
NA
Cancer
Variola virus
Yamamoto P
NA
Focus forming assay
Decrease (2.9 %)
NA
198636
DrugRepV_5250Cytarabine
NA
Leukemia
Variola virus
Butler
NA
Focus forming assay
Decrease (44.4 %)
Approved
198636
DrugRepV_52516-Azauridine
NA
Cancer
Variola virus
Butler
NA
Focus forming assay
No significant effect (No inhibition %)
NA
198636
DrugRepV_5633Minocycline
Antiinfectives For Systemic Use
Rocky Mountain spotted fever | Typhus fever and the typhus group | Q fever | Rickettsial pox | tick fevers caused by Rickettsiae | Upper respiratory tract infections caused by Streptococcus pneumoniae
Dengue virus
16681
Pathway
Focus forming assay
Decrease (1 Log10 (FFU/ml))
Approved, Investigational
27396621
DrugRepV_6019Saracatinib
Anticancer
Cancer
Dengue virus
New Guinea C
Pathway
Focus forming assay
Decrease (90 %)
Investigational
23616652
DrugRepV_6020Dasatinib
Antineoplastic and Immunomodulating Agents
Cancer
Dengue virus
New Guinea C
Pathway
Focus forming assay
Decrease (90 %)
Approved
23616652
DrugRepV_6021Dasatinib
Antineoplastic and Immunomodulating Agents
Cancer
Dengue virus
New Guinea C
Pathway
Focus forming assay
Decrease (1 Log)
Approved
23616652
DrugRepV_6034Aminolevullic acid
Antineoplastic and Immunomodulating Agents
NA
Dengue virus
16681
Pathway
Focus forming assay
Decrease (41.1 %)
NA
30055216
DrugRepV_6035Azelaic acid
Dermatologicals
Acne vulgaris
Dengue virus
16681
Pathway
Focus forming assay
Decrease (36.6 %)
Approved
30055216
DrugRepV_6036Mitoxantrone hydrochloride
Antineoplastic and Immunomodulating Agents
Multiple sclerosis
Dengue virus
16681
Pathway
Focus forming assay
Decrease (53.8 %)
NA
30055216
DrugRepV_6037Quinine sulfate
Antiparasitic products, Insectisides and Repellents
Malaria | Leg cramps
Dengue virus
16681
Pathway
Focus forming assay
Decrease (81 %)
NA
30055216
DrugRepV_6130VGTI-A3
NA
NA
Dengue virus
New Guinea C
Pathway
Focus forming assay
Decrease (90 %)
NA
29709563
DrugRepV_6131VGTI-A3-03
NA
NA
Dengue virus
New Guinea C
Pathway
Focus forming assay
Decrease (90 %)
NA
29709563
DrugRepV_6256Heparin
Blood and Blood Forming Organs
Venous thrombosis
Dengue virus
D1/Lao/03
Pathway
Focus forming assay
Decrease (50 %)
Approved, Investigational
20851716
DrugRepV_6257Heparin
Blood and Blood Forming Organs
Venous thrombosis
Dengue virus
ThNH-7/93
Pathway
Focus forming assay
Decrease (50 %)
Approved, Investigational
20851716
DrugRepV_6258Heparin
Blood and Blood Forming Organs
Venous thrombosis
Dengue virus
D3/BDH02-01
Pathway
Focus forming assay
Decrease (50 %)
Approved, Investigational
20851716
DrugRepV_6259Heparin
Blood and Blood Forming Organs
Venous thrombosis
Dengue virus
ThD 17/97
Pathway
Focus forming assay
Decrease (50 %)
Approved, Investigational
20851716
DrugRepV_7003Sunitinib
Antineoplastic and Immunomodulating Agents
Renal cell carcinoma | Gastrointestinal stromal tumor
West Nile virus
NY 99 3000.0259
Pathway
Focus forming assay
Decrease (50 %)
Approved, Investigational
28240606
DrugRepV_7261Heparin
Blood and Blood Forming Organs
Venous thrombosis
Japanese encephalitis virus
JaOArS982
Pathway
Focus forming assay
Decrease (50 %)
Approved, Investigational
20851716